back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Recent filings | ||||||
| Filed 2025-07-11 16:59 Tx date 2025-06-02 |
$GUD
Knight Therapeutics Inc. |
Gale, James
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-161,000
-20,000 vol $8.05 each |
70,000 | |
| Older filings | ||||||
| Filed 2025-06-10 11:00 Tx date 2025-06-06 |
$GUD
Knight Therapeutics Inc. |
Gale, James
4 - Director of Issuer
Direct Ownership
|
Deferred Stock Unit
56 - Grant of rights
|
$59,999
+10,118 vol $5.93 each |
49,194 | |
| Filed 2024-05-21 13:25 Tx date 2024-05-17 |
$GUD
Knight Therapeutics Inc. |
Gale, James
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$7,644
+1,353 vol $5.65 each |
52,406 | |
| Filed 2024-05-21 13:23 Tx date 2024-05-17 |
$GUD
Knight Therapeutics Inc. |
Gale, James
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-113,000
-20,000 vol $5.65 each |
90,000 | |
| Filed 2024-05-13 13:22 Tx date 2024-05-10 |
$GUD
Knight Therapeutics Inc. |
Gale, James
4 - Director of Issuer
Direct Ownership
|
Deferred Stock Unit
56 - Grant of rights
|
$54,998
+9,259 vol $5.94 each |
39,076 | |
| Filed 2023-05-15 11:50 Tx date 2023-05-12 |
$GUD
Knight Therapeutics Inc. |
Gale, James
4 - Director of Issuer
Direct Ownership
|
Deferred Stock Unit
56 - Grant of rights
|
$54,995
+11,316 vol $4.86 each |
29,817 | |
| Filed 2023-03-21 21:20 Tx date 2023-03-17 |
$GUD
Knight Therapeutics Inc. |
Gale, James
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-155,200
-20,000 vol $7.76 each |
110,000 | |
| Filed 2022-05-16 10:00 Tx date 2022-05-13 |
$GUD
Knight Therapeutics Inc. |
Gale, James
4 - Director of Issuer
Direct Ownership
|
Deferred Stock Unit
56 - Grant of rights
|
$54,997
+10,536 vol $5.22 each |
18,501 | |
| Filed 2022-03-30 17:00 Tx date 2022-03-25 |
$GUD
Knight Therapeutics Inc. |
Gale, James
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-175,000
-20,000 vol $8.75 each |
130,000 | |
| Filed 2021-05-24 15:34 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Gale, James
4 - Director of Issuer
Direct Ownership
|
Deferred Stock Unit
56 - Grant of rights
|
$45,002
+7,965 vol $5.65 each |
7,965 | |
| Filed 2021-05-20 13:01 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Gale, James
4 - Director of Issuer
Direct Ownership
|
Deferred Stock Unit
97 - Other
|
$45,002
+7,965 vol $5.65 each |
||
| Filed 2021-05-20 11:24 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Gale, James
4 - Director of Issuer
Direct Ownership
|
Deferred Stock Unit
97 - Other
|
$45,002
+7,965 vol $5.65 each |
||
| Filed 2021-05-20 13:01 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Gale, James
4 - Director of Issuer
Direct Ownership
|
Deferred Stock Unit
97 - Other
|
$45,002
+7,965 vol $5.65 each |
7,965 | |
| Filed 2021-05-20 13:00 Tx date 2014-02-28 |
$GUD
Knight Therapeutics Inc. |
Gale, James
4 - Director of Issuer
Direct Ownership
|
Deferred Stock Unit
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-05-20 12:59 Tx date 2014-06-02 |
$GUD
Knight Therapeutics Inc. |
Gale, James
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+20,000 vol |
20,000 | |
| Filed 2021-05-20 11:24 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Gale, James
4 - Director of Issuer
Direct Ownership
|
Deferred Stock Unit
97 - Other
|
$45,002
+7,965 vol $5.65 each |
7,965 | |
| Filed 2021-05-20 11:24 Tx date 2021-05-18 |
$GUD
Knight Therapeutics Inc. |
Gale, James
4 - Director of Issuer
Direct Ownership
|
Deferred Stock Unit
97 - Other
|
$45,002
+7,965 vol $5.65 each |
||
| Filed 2021-05-20 11:23 Tx date 2014-02-28 |
$GUD
Knight Therapeutics Inc. |
Gale, James
4 - Director of Issuer
Direct Ownership
|
Deferred Stock Unit
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-05-20 11:23 Tx date 2014-02-28 |
$GUD
Knight Therapeutics Inc. |
Gale, James
4 - Director of Issuer
Direct Ownership
|
Deferred Stock Unit
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-05-20 11:22 Tx date 2014-06-02 |
$GUD
Knight Therapeutics Inc. |
Gale, James
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+20,000 vol |
||
| Filed 2021-05-20 11:22 Tx date 2014-06-02 |
$GUD
Knight Therapeutics Inc. |
Gale, James
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+20,000 vol |
20,000 | |
| Filed 2014-06-05 11:20 Tx date 2014-06-02 |
$GUD
Knight Therapeutics Inc. |
Gale, James
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+20,000 vol |
||
| Filed 2014-06-05 11:20 Tx date 2014-06-02 |
$GUD
Knight Therapeutics Inc. |
Gale, James
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+20,000 vol |
||
| Filed 2021-01-14 15:24 Tx date 2021-01-14 |
$GUD
Knight Therapeutics Inc. |
Gale, James
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,650
+500 vol $5.30 each |
51,053 | |
| Filed 2021-01-14 15:20 Tx date 2021-01-14 |
$GUD
Knight Therapeutics Inc. |
Gale, James
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$23,714
+4,500 vol $5.27 each |
50,553 | |
| Filed 2021-01-14 15:17 Tx date 2021-01-14 |
$GUD
Knight Therapeutics Inc. |
Gale, James
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$23,714
+4,500 vol $5.27 each |
||
| Filed 2020-07-03 16:38 Tx date 2020-07-01 |
$GUD
Knight Therapeutics Inc. |
Gale, James
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+25,000 vol |
150,000 | |
| Filed 2019-05-15 15:26 Tx date 2019-05-14 |
$GUD
Knight Therapeutics Inc. |
Gale, James
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+25,000 vol |
125,000 | |
| Filed 2018-05-16 Tx date 2018-05-15 |
$GUD
Knight Therapeutics Inc. |
Gale, James
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+20,000 vol |
100,000 | |
| Filed 2017-05-17 Tx date 2017-05-16 |
$GUD
Knight Therapeutics Inc. |
Gale, James
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+20,000 vol |
80,000 | |
| Filed 2015-12-18 Tx date 2015-12-16 |
$GUD
Knight Therapeutics Inc. |
Gale, James
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+20,000 vol |
60,000 | |